Orphenadrine Citrate, Aspirin and Caffeine
- Product NDC
- 71993-999
- 11-digit product format
- 719930999
- Labeler code
- 71993
- Product ID
- 71993-999_9bbb2502-f443-eebb-e053-2a95a90aa47b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Orphenadrine Citrate, Aspirin and Caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Atland Pharmaceuticals, LLC
- Application
- ANDA075141
- Marketing category
- ANDA
- Marketing start
- 2019-06-21
- Marketing end
- 0000-00-00
- Substance
- ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE
- Active strength
- 50 mg/1; mg/1; mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record